← Back to Search

Vitamin

Vitamin C for Sepsis

Phase 2
Waitlist Available
Led By Michael D Sharpe, MD FRCPC
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days or discharge from intensive care unit
Awards & highlights

Study Summary

This study is designed to determine if Vitamin C administration to septic patients will result in an improvement in organ dysfunction which occurs during a septic illness. Hypothesis: 1. Vitamin C in sepsis will reduce the injury to organs 2. Vitamin C will reduce the length of time on a ventilator, length of stay in the intensive care unit and in hospital.

Eligible Conditions
  • Sepsis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days or discharge from intensive care unit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days or discharge from intensive care unit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sequential organ function assessment score (SOFA)
Secondary outcome measures
Biomarkers as a measure of coagulation, inflammation and oxidative stress.

Side effects data

From 2018 Phase 2 trial • 20 Patients • NCT03148236
10%
Pericarditis
100%
80%
60%
40%
20%
0%
Study treatment Arm
Vitamin C
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Vitamin CExperimental Treatment1 Intervention
Intravenous Vitamin C will be administered (1 gram) every 8 hours for 28 days or discharge from intensive care unit
Group II: placeboPlacebo Group1 Intervention
placebo vehicle administered in same fashion as active treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ascorbic acid
FDA approved

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
659 Previous Clinical Trials
413,712 Total Patients Enrolled
5 Trials studying Sepsis
1,750 Patients Enrolled for Sepsis
Michael D Sharpe, MD FRCPCPrincipal InvestigatorLondon Health Sciences Centre
2 Previous Clinical Trials
54 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025